Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 1999, p. 696-700, Vol. 6, No. 5
Blood Transfusion Service and Internal Medicine,
Received 19 January 1999/Returned for modification 4 May
1999/Accepted 7 June 1999
The prevalence of Borna disease virus (BDV)-specific antibodies
among patients with psychiatric disorders and healthy individuals has
varied in several reports using several different serological assay
methods. A reliable and specific method for anti-BDV antibodies needs
to be developed to clarify the pathological significance of BDV
infections in humans. We developed a new electrochemiluminescence immunoassay (ECLIA) for the antibody to BDV that uses two recombinant proteins of BDV, p40 and p24 (full length). Using this ECLIA, we
examined 3,476 serum samples from humans with various diseases and 917 sera from blood donors in Japan for the presence of anti-BDV antibodies. By ECLIA, 26 (3.08%) of 845 schizophrenia patients and 9 (3.59%) of 251 patients with mood disorders were seropositive for BDV.
Among 323 patients with other psychiatric diseases, 114 with
neurological diseases, 75 with chronic fatigue syndrome, 85 human
immunodeficiency virus-infected patients, 50 with autoimmune diseases
including rheumatoid arthritis and systemic lupus erythematosis and 17 with leprosy, there was no positive case except one case each with
alcohol addiction, AIDS, and dementia. Although 19 (1.36%) of 1,393 patients with various ocular diseases, 10 (1.09%) of 917 blood donors,
and 3 (4.55%) of 66 multitransfused patients were seropositive for
BDV-specific antigen, high levels of seroprevalence in schizophrenia
patients and young patients (16 to 59 years old) with mood disorders
were statistically significant. The immunoreactivity of seropositive
sera could be verified for specificity by blocking with soluble p40
and/or p24 recombinant protein. Anti-p24 antibody was more frequent
than p40 antibody in most cases, and in some psychotic patients
antibody profiles showed only p40 antibody. Although serum positive for
both p40 and p24 antibodies was not found in this study, the p40 ECLIA
count in schizophrenia patients was higher than that of blood donors.
Furthermore, we examined 90 sera from Japanese feral horses. Antibody
profiles of control human samples are similar to that of naturally
BDV-infected feral horses. We concluded that BDV infection was
associated in some way with psychiatric disorders.
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Detection of Borna Disease Virus-Reactive
Antibodies from Patients with Psychiatric Disorders and from Horses by
Electrochemiluminescence Immunoassay
*
Corresponding author. Mailing address: Blood
Transfusion Service, Kumamoto University School of Medicine, Honjo
1-1-1, Kumamoto 860, Japan. Phone: 81-96-373-5811. Fax:
81-96-373-5813. E-mail: kyama{at}gpo.kumamoto-u.ac.jp.
Clinical and Diagnostic Laboratory Immunology, September 1999, p. 696-700, Vol. 6, No. 5
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»